DK0886644T3 - Lang bölgelængde-modificerede fluorescerende proteiner - Google Patents

Lang bölgelængde-modificerede fluorescerende proteiner

Info

Publication number
DK0886644T3
DK0886644T3 DK97941350T DK97941350T DK0886644T3 DK 0886644 T3 DK0886644 T3 DK 0886644T3 DK 97941350 T DK97941350 T DK 97941350T DK 97941350 T DK97941350 T DK 97941350T DK 0886644 T3 DK0886644 T3 DK 0886644T3
Authority
DK
Denmark
Prior art keywords
fluorescent proteins
long wavelength
modified fluorescent
image
modified
Prior art date
Application number
DK97941350T
Other languages
Danish (da)
English (en)
Inventor
Roger Y Tsien
Andrew B Cubitt
Roger Heim
Mats F Ormo
James S Remington
Original Assignee
Univ California
Oregon State
Invitrogen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, Oregon State, Invitrogen Corp filed Critical Univ California
Application granted granted Critical
Publication of DK0886644T3 publication Critical patent/DK0886644T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/968—High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK97941350T 1996-08-16 1997-08-15 Lang bölgelængde-modificerede fluorescerende proteiner DK0886644T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2405096P 1996-08-16 1996-08-16
US08/706,408 US6124128A (en) 1996-08-16 1996-08-30 Long wavelength engineered fluorescent proteins
PCT/US1997/014593 WO1998006737A1 (fr) 1996-08-16 1997-08-15 Proteines fluorescentes manipulees a grande longueur d'onde

Publications (1)

Publication Number Publication Date
DK0886644T3 true DK0886644T3 (da) 2005-03-14

Family

ID=26697970

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97941350T DK0886644T3 (da) 1996-08-16 1997-08-15 Lang bölgelængde-modificerede fluorescerende proteiner

Country Status (10)

Country Link
US (6) US6124128A (fr)
EP (2) EP1508574A3 (fr)
JP (1) JP4232992B2 (fr)
AT (1) ATE280178T1 (fr)
AU (1) AU727088B2 (fr)
CA (1) CA2232242C (fr)
DE (1) DE69731285T2 (fr)
DK (1) DK0886644T3 (fr)
ES (1) ES2231890T3 (fr)
WO (1) WO1998006737A1 (fr)

Families Citing this family (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0851874T3 (da) * 1995-09-22 2000-03-06 Bioimage A S Hidtil ukendte varianter af grønt fluorescerende protein, GFP
US6803188B1 (en) * 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
US6593135B2 (en) * 1996-08-16 2003-07-15 The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Long wavelength engineered fluorescent proteins
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
WO1998021355A1 (fr) 1996-11-15 1998-05-22 Life Technologies, Inc. Mutants de la proteine fluorescente verte
WO1998036081A2 (fr) 1997-02-13 1998-08-20 Memorial Sloan-Kettering Cancer Center Molecules hybrides pour la detection optique des modifications des micro-environnements cellulaires
US6197928B1 (en) 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
EP0970199B1 (fr) * 1997-03-14 2008-10-22 The Regents Of The University Of California Detecteurs de proteines fluorescentes permettant de detecter des substances a analyser
US7105307B2 (en) 1997-08-30 2006-09-12 Cyclacel, Ltd. Compositions and methods for screening for modulators of enzymatic activity
US6881683B2 (en) * 1998-02-05 2005-04-19 Asm Japan K.K. Insulation film on semiconductor substrate and method for forming same
US7090976B2 (en) * 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US6140132A (en) * 1998-06-09 2000-10-31 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
US6150176A (en) * 1998-06-09 2000-11-21 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
JP2002542453A (ja) * 1998-08-08 2002-12-10 インペリアル キャンサー リサーチ テクノロジー リミテッド 生物学的系についての蛍光分析法
US6656696B2 (en) 1999-02-26 2003-12-02 Cyclacel Compositions and methods for monitoring the phosphorylation of natural binding partners
US6670144B1 (en) 1999-02-26 2003-12-30 Cyclacel, Ltd. Compositions and methods for monitoring the phosphorylation of natural binding partners
US6828106B2 (en) * 1999-02-26 2004-12-07 Cyclacel Limited Methods and compositions using coiled binding partners
US6972182B1 (en) * 1999-02-26 2005-12-06 Cyclacel, Ltd. Methods and compositions using coiled binding partners
US6716614B1 (en) * 1999-09-02 2004-04-06 Lexicon Genetics Incorporated Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
US6541252B1 (en) 2000-05-19 2003-04-01 Lexicon Genetics Incorporated Human kinases and polynucleotides encoding the same
US6562563B1 (en) 1999-11-03 2003-05-13 Mitokor Compositions and mehtods for determining interactions of mitochondrial components, and for identifying agents that alter such interactions
US7060506B2 (en) 2000-01-31 2006-06-13 Cyclacel, Ltd. Compositions and methods for monitoring the modification of modification dependent binding partner polypeptides
US6656700B2 (en) 2000-05-26 2003-12-02 Amersham Plc Isoforms of human pregnancy-associated protein-E
US6686188B2 (en) 2000-05-26 2004-02-03 Amersham Plc Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
US6808874B2 (en) 2000-06-13 2004-10-26 Cyclacel Ltd. Methods of monitoring enzyme activity
JP2005518180A (ja) * 2000-06-19 2005-06-23 バイオイメージ　エイ／エス 新規蛍光タンパク質
US20040072995A1 (en) * 2000-06-19 2004-04-15 Bjorn Sara P. Novel fluorescent proteins
US6667153B1 (en) 2000-06-26 2003-12-23 Susan Margaret Thomas Composition and method for detecting mutagens
US20020123474A1 (en) * 2000-10-04 2002-09-05 Shannon Mark E. Human GTP-Rho binding protein2
JP2004533221A (ja) * 2000-10-27 2004-11-04 レキシコン・ジェネティクス・インコーポレーテッド 新規ヒト７ｔｍタンパクおよびそれをコードするポリヌクレオチド
CA2427701A1 (fr) * 2000-10-30 2002-05-10 Lexicon Genetics Incorporated Nouvelles proteines humaines 7tm et polynucleotides codant pour ces proteines
EP1343973B2 (fr) 2000-11-16 2020-09-16 California Institute Of Technology Appareil et procedes pour effectuer des dosages et des criblages a haut rendement
US7005511B2 (en) 2001-02-26 2006-02-28 The Regents Of The University Of California Fluorescent protein variants and methods for making same
JP3929250B2 (ja) * 2001-03-08 2007-06-13 株式会社ルネサステクノロジ 半導体装置
AU2002254173A1 (en) * 2001-03-12 2002-10-08 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The Unive Oxidation-reduction sensitive green fluorescent protein variants
GB0109858D0 (en) * 2001-04-23 2001-06-13 Amersham Pharm Biotech Uk Ltd Fluorscent proteins
AU2002309865A1 (en) * 2001-05-15 2002-11-25 University Of Medicine & Dentistry Of New Jersey Methods for analyzing interactions between proteins in live and intact cells
AU2002309989A1 (en) * 2001-05-18 2002-12-03 Rigel Pharmaceuticals, Incorporated Directed evolution of protein in mammalian cells
US7354735B2 (en) * 2001-05-24 2008-04-08 Hong Kong University Of Science And Technology Nucleic acid encoding fluorescent protein constructs and methods for detecting apoptosis
JP3829252B2 (ja) * 2001-06-08 2006-10-04 独立行政法人理化学研究所 蛍光蛋白質
US20040078837A1 (en) * 2001-08-02 2004-04-22 Shannon Mark E. Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12
US20040096880A1 (en) * 2001-08-07 2004-05-20 Kmiec Eric B. Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
WO2003013437A2 (fr) * 2001-08-07 2003-02-20 University Of Delaware Compositions et procedes de prevention et traitement de la maladie d'huntington
WO2003017937A2 (fr) * 2001-08-22 2003-03-06 University Of Hawaii Proteines fluorescentes de physalia
US20030027315A1 (en) * 2001-09-24 2003-02-06 Ada Yonath Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals
WO2003029827A2 (fr) * 2001-10-01 2003-04-10 Bioimage A/S Methode amelioree permettant de detecter des interactions entre des constituants cellulaires presents dans des cellules vivantes intactes et d'extraire des informations quantitatives se rapportant auxdites interactions par nouvelle repartition de fluorescence
GB0123856D0 (en) * 2001-10-05 2001-11-28 Amersham Pharm Biotech Uk Ltd Method for determining cell cycle position
AU2002363466A1 (en) * 2001-10-24 2003-05-19 University Of Hawaii Multifunctional green fluorescent protein and uses thereof
AU2002350039A1 (en) * 2001-10-29 2003-05-12 Renovis, Inc. Method for isolating cell-type specific mrnas
US7846671B2 (en) 2002-01-28 2010-12-07 Bristol-Myers Squibb Company Methods of screening for agents that modulate the interaction of RGS and Gαq and urinary incontinence
GB0207533D0 (en) 2002-04-02 2002-05-08 Oxford Glycosciences Uk Ltd Protein
US20050181464A1 (en) * 2002-04-04 2005-08-18 Affinium Pharmaceuticals, Inc. Novel purified polypeptides from bacteria
US7335488B2 (en) * 2002-04-05 2008-02-26 The Chinese University Of Hong Kong Fluorescent proteins
PT1534819E (pt) 2002-08-21 2010-03-11 Revivicor Inc Animais porcinos carecendo de qualquer expressão de alfa 1,3-galactosiltransferase funcional
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
US7056683B2 (en) * 2002-11-12 2006-06-06 Massachusetts Institute Of Technology Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities
WO2004090115A2 (fr) 2003-04-04 2004-10-21 Stratagene Mutants de proteines vertes fluorescentes derives de ranilla a intensite de fluorescence amelioree et mutants a remaniement special
US20050037364A1 (en) 2003-08-13 2005-02-17 International Business Machines Corporation Techniques for recording signals
US20050048493A1 (en) * 2003-08-27 2005-03-03 Zyomyx, Inc. Film layer for detection of immobilized analytes
US7279275B2 (en) 2003-11-03 2007-10-09 Washington University Methods and compositions for detection of segmented negative strand RNA viruses
EP2412816B1 (fr) 2004-07-26 2014-12-03 Pfenex Inc. Procédé permettant d'améliorer l'expression d'une protéine par mise au point d'une souche par génie génétique
US20090263821A1 (en) 2004-12-01 2009-10-22 Proteologics, Inc. Ubiquitin Ligase Assays And Related Reagents
DK1920248T3 (da) 2005-04-05 2010-12-13 Allergan Inc Clostridialt-toksin-aktivitetsassays
JP5047950B2 (ja) 2005-05-18 2012-10-10 アブリンクス エン．ヴェー． 腫瘍壊死因子−アルファに対する改良ナノボディ（商標）
ES2852423T3 (es) 2005-05-20 2021-09-13 Ablynx Nv NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
US8362250B2 (en) 2005-05-24 2013-01-29 Enzo Biochem, Inc. Fluorescent dyes and compounds, methods and kits useful for identifying specific organelles and regions in cells of interest
CA2617930A1 (fr) 2005-08-09 2007-03-29 Revivicor, Inc. Ongules transgeniques exprimant la ctla4-ig et leurs utilisations
RU2412250C2 (ru) * 2005-11-04 2011-02-20 Закрытое акционерное общество "ЕВРОГЕН" Модифицированные зеленые флуоресцентные белки и способы их использования
US8067237B2 (en) 2005-12-13 2011-11-29 President And Fellows Of Harvard College Scaffolds for cell transplantation
JP4719226B2 (ja) * 2006-01-26 2011-07-06 Ｎｅｃソフト株式会社 蛍光タンパク質の蛍光波長を変える方法
KR20080113236A (ko) * 2006-03-21 2008-12-29 와이어쓰 Ｒａｇｅ를 길항하기 위한 방법 및 조성물
GB0606430D0 (en) * 2006-03-31 2006-05-10 Ge Healthcare Uk Ltd Method for cell based assays
US20080004410A1 (en) * 2006-06-30 2008-01-03 Yu-Chin Lai Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
GB0624462D0 (en) * 2006-12-07 2007-01-17 Ge Healthcare Ltd Method for determining gentoxicity
US9156914B2 (en) 2006-12-19 2015-10-13 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
EP2557090A3 (fr) 2006-12-19 2013-05-29 Ablynx N.V. Séquences d'acides aminés dirigées contre les GPCR et polypeptides les comprenant pour le traitement de maladies et de troubles liés au GPCR
JP5370890B2 (ja) * 2007-03-16 2013-12-18 公益財団法人東京都医学総合研究所 細胞周期可視化プローブ
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
CA2685326A1 (fr) 2007-04-27 2008-11-06 Dow Global Technologies Inc. Procede pour rapidement cribler des hotes microbiens et identifier certaines souches ayant un rendement et/ou une qualite d'expression des proteines heterologues ameliores
WO2009002401A2 (fr) 2007-06-21 2008-12-31 President And Fellows Of Harvard College Échafaudages pour recueil ou élimination de cellules
US9097667B2 (en) * 2007-12-14 2015-08-04 Biotium, Inc. Fluorescent compounds
GB0800938D0 (en) * 2008-01-18 2008-02-27 Ge Healthcare Uk Ltd Multiplex cell signalling assay
JP5690143B2 (ja) 2008-02-13 2015-03-25 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 持続的細胞プログラミング装置
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
WO2009114185A2 (fr) 2008-03-12 2009-09-17 The Rockefeller University Procédés et compositions pour profil translationnel et phénotypage moléculaire
EP2260058A2 (fr) 2008-04-07 2010-12-15 Ablynx N.V. Séquences d acides aminés dirigées contre les voies notch et leurs utilisations
WO2009146456A1 (fr) * 2008-05-30 2009-12-03 President And Fellows Of Harvard College Libération contrôlée de facteurs de croissance et de molécules de signalisation pour favoriser l’angiogenèse
US20100017232A1 (en) * 2008-07-18 2010-01-21 StevenDale Software, LLC Information Transmittal And Notification System
US7935492B2 (en) * 2008-07-22 2011-05-03 Fibrostatin, Sociedad Limitada Goodpasture antigen binding protein and its detection
US9334281B2 (en) * 2008-09-08 2016-05-10 Enzo Life Sciences, Inc. Fluorochromes for organelle tracing and multi-color imaging
US9250249B2 (en) 2008-09-08 2016-02-02 Enzo Biochem, Inc. Autophagy and phospholipidosis pathway assays
DK2370465T3 (da) 2008-12-19 2019-05-06 Ablynx Nv Genetisk immunisering til fremstilling af immunoglobuliner mod celleassocierede antigener, såsom p2x7, cxcr7 eller cxcr4
RU2539798C2 (ru) 2009-04-10 2015-01-27 Аблинкс Нв Улучшенные аминокислотные последовательности против il-6r и содержащие их полипептиды для лечения связанных с il-6r заболеваний и нарушений
US9297005B2 (en) 2009-04-13 2016-03-29 President And Fellows Of Harvard College Harnessing cell dynamics to engineer materials
CN105061592A (zh) 2009-06-05 2015-11-18 埃博灵克斯股份有限公司 用于预防和/或治疗呼吸道感染的单价、二价和三价抗人呼吸道合胞病毒(hrsv)纳米抗体构建体
AU2010278702C1 (en) 2009-07-31 2016-07-14 Forsyth Dental Infirmary For Children Programming of cells for tolerogenic therapies
US8741591B2 (en) 2009-10-09 2014-06-03 The Research Foundation For The State University Of New York pH-insensitive glucose indicator protein
US8658434B2 (en) * 2009-10-28 2014-02-25 Biotium, Inc. Fluorescent pyrene compounds
EP2507262A1 (fr) 2009-11-30 2012-10-10 Ablynx N.V. Séquences d'acides aminés améliorées dirigées contre le virus syncytial respiratoire humain (hrsv) et polypeptides comprenant celles-ci pour la prévention et/ou le traitement d'infections du tractus respiratoire
WO2011083141A2 (fr) 2010-01-08 2011-07-14 Ablynx Nv Procédé de production de séquences d'immunoglobulines par utilisation de particules de lipoprotéines
DE102010009445A1 (de) 2010-02-25 2011-08-25 Universitätsklinikum Jena, 07743 Expressionsvektor zur Enzym-Expression in Zellen und Verfahren zu dessen Verwendung
EP2542230A4 (fr) 2010-03-05 2013-08-28 Harvard College Amélioration de prise de greffe de cellule-souche de muscle squelettique par double apport de vegf et d'igf-1
EP2585053A4 (fr) 2010-06-25 2014-02-26 Harvard College Coadministration de facteurs stimulants et inhibiteurs afin de créer des zones spatialement restreintes et temporellement stables
AU2011272941B2 (en) 2010-06-30 2014-05-29 Compugen Ltd. C10RF32 for the treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CA2807942C (fr) 2010-08-10 2021-07-27 Ecole Polytechnique Federale De Lausanne Agents therapeutiques se liant aux erythrocytes
US9517257B2 (en) 2010-08-10 2016-12-13 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
CN103221070B (zh) 2010-08-30 2019-07-12 哈佛大学校长及研究员协会 用于狭窄病变和溶解血栓疗法的切变控制释放
US8999335B2 (en) 2010-09-17 2015-04-07 Compugen Ltd. Compositions and methods for treatment of drug resistant multiple myeloma
CN107648668B (zh) 2010-10-06 2021-06-18 哈佛学院董事会 用于基于材料的细胞疗法的可注射的成孔水凝胶
US9603894B2 (en) 2010-11-08 2017-03-28 President And Fellows Of Harvard College Materials presenting notch signaling molecules to control cell behavior
MX2013009647A (es) 2011-02-21 2014-02-03 Fibrostatin S L Metodos para tratar y diagnosticar enfermedades.
EP2701753B1 (fr) 2011-04-27 2018-12-26 President and Fellows of Harvard College Hydrogels d'opale inverse n'endommageant pas les cellules pour encapsulation cellulaire, administration de médicament et de protéine, et encapsulation de nanoparticule fonctionnelle
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
EP2701745B1 (fr) 2011-04-28 2018-07-11 President and Fellows of Harvard College Échafaudages tridimensionnels macroscopiques préformés injectables pour l'administration minimalement invasive
WO2012162249A1 (fr) 2011-05-20 2012-11-29 Benjamin Wolozin Identification de composés qui dispersent des inclusions de tdp-43
US9486512B2 (en) 2011-06-03 2016-11-08 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
RU2014110901A (ru) 2011-08-23 2015-09-27 Президент Энд Феллоуз Ов Харвард Колледж Пептидные частицы и их применение
GB201121570D0 (en) 2011-12-15 2012-01-25 Fundaci Privada Ct De Regulaci Gen Mica Crg Methods for producing engineered fluorescent proteins for enhanced fret, products and uses thereof
GB201121565D0 (en) 2011-12-15 2012-01-25 Fundaci Privada Ct De Regulaci Gen Mica Crg Engineering fluorescent proteins for enhanced fret and uses thereof
CA2859761C (fr) 2011-12-22 2023-06-20 President And Fellows Of Harvard College Compositions et procedes pour la detection d'analytes
WO2013130808A1 (fr) 2012-02-29 2013-09-06 D.E. Shaw Research, Llc Procédés pour le criblage de protéines sensibles à la tension
WO2013158673A1 (fr) 2012-04-16 2013-10-24 President And Fellows Of Harvard College Compositions de silice mésoporeuse pour moduler les réponses immunitaires
WO2013184950A2 (fr) 2012-06-06 2013-12-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Kits pour détecter et surveiller les produits chimiques qui sont des perturbateurs endocriniens (edc)
WO2014006020A1 (fr) 2012-07-02 2014-01-09 Fibrostatin, S.L. Inhibition de gpbp-1 et son utilisation thérapeutique
US9682123B2 (en) 2013-12-20 2017-06-20 The Trustees Of Columbia University In The City Of New York Methods of treating metabolic disease
US10046056B2 (en) 2014-02-21 2018-08-14 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
US10946079B2 (en) 2014-02-21 2021-03-16 Ecole Polytechnique Federale De Lausanne Glycotargeting therapeutics
DK3107563T3 (da) 2014-02-21 2021-05-25 Ecole Polytechnique Fed De Lausanne Epfl Epfl Tto Glycomålrettede terapeutiske midler
US10953101B2 (en) 2014-02-21 2021-03-23 École Polytechnique Fédérale De Lausanne (Epfl) Glycotargeting therapeutics
JP6789823B2 (ja) 2014-04-15 2020-11-25 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 両末端ｐｅｇ化インテグリン結合性ペプチドおよびその使用方法
CN107073090A (zh) 2014-04-30 2017-08-18 哈佛学院董事会 结合的疫苗装置和杀死癌细胞的方法
NL2013661B1 (en) 2014-10-21 2016-10-05 Ablynx Nv KV1.3 Binding immunoglobulins.
WO2016007886A1 (fr) 2014-07-11 2016-01-14 Northwestern University Biocapteur à base de levure
WO2016090313A1 (fr) 2014-12-05 2016-06-09 Aquinnah Pharmaceuticals, Inc. Composés, compositions et procédés d'utilisation associés
CA2969756A1 (fr) 2014-12-05 2016-06-09 Aquinnah Pharmaceuticals, Inc. Derives de sulfonamide, compositions et procedes d'utilisation dans le traitement de maladies neurodegeneratives
WO2016123573A1 (fr) 2015-01-30 2016-08-04 President And Fellows Of Harvard College Matériaux péritumoraux et intratumoraux pour traitement anticancéreux
CN114099793A (zh) 2015-04-10 2022-03-01 哈佛学院院长等 免疫细胞捕获装置及其制备和使用方法
CA2991980A1 (fr) 2015-07-13 2017-01-19 Compugen Ltd. Compositions de hide1 et methodes associees
EP3702470A3 (fr) 2015-09-09 2020-10-07 The Trustees of Columbia University in the City of New York Réduction du fragment c99 de l'app localisé sur la membrane er-mam et procédés de traitement de la maladie d'alzheimer
CA3001857A1 (fr) 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Composes, compositions et methodes d'utilisation contre des granules de stress
US20180312534A1 (en) 2015-10-16 2018-11-01 Invictus Oncology Pvt. Ltd. Fluorescent anticancer platinum drugs
WO2017136837A1 (fr) 2016-02-06 2017-08-10 President And Fellows Of Harvard College Régénération de la niche hématopoïétique pour reconstituer l'immunité
CN115537372A (zh) 2016-07-13 2022-12-30 哈佛学院院长等 抗原呈递细胞模拟支架及其制备和使用方法
US11840569B2 (en) 2016-11-16 2023-12-12 Ablynx N.V. T cell recruiting polypeptides capable of binding CD123 and TCR alpha/beta
WO2018232176A1 (fr) 2017-06-16 2018-12-20 The University Of Chicago Compositions et procédés d'induction d'une tolérance immunitaire
WO2019136421A1 (fr) * 2018-01-08 2019-07-11 Lucidicor Inc. Biocapteur de protéine fluorescente pour la détection de l'activité kinase
US20200392512A1 (en) 2018-02-26 2020-12-17 Ablynx N.V. Nucleotide sequences encoding peptide linkers
BR102019017792A2 (pt) 2019-08-27 2021-11-16 Fundação Oswaldo Cruz Receptáculo proteico, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, e, uso do receptáculo
CA3180508A1 (fr) 2020-04-17 2021-10-21 Regeneron Pharmaceuticals, Inc. Dosages de detection pour des anticorps neutralisant le coronavirus
CN113265428B (zh) * 2021-06-11 2023-03-14 东北林业大学 一种利用金属硫蛋白构建活细胞内铜变化的检测系统及应用
CA3227194A1 (fr) 2021-07-30 2023-02-02 Ann De Blieck Composes pour le traitement de la douleur, en particulier de la douleur neuropathique, et/ou d'autres maladies ou troubles associes a at2r et/ou a la signalisation mediee par at2r

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK487784A (da) * 1983-10-13 1985-04-14 Univ Georgia Immunoassay
JPS6439990A (en) * 1987-08-05 1989-02-10 Chisso Corp Fused gene by bonding aequorin gene to functional gene
GB8916806D0 (en) * 1989-07-22 1989-09-06 Univ Wales Medicine Modified proteins
GB9310978D0 (en) * 1993-05-27 1993-07-14 Zeneca Ltd Compounds
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
EP0759170B1 (fr) * 1993-09-10 2008-07-09 The Trustees Of Columbia University In The City Of New York Methodes d'utilisation de protéine fluorescente verte
WO1995021191A1 (fr) * 1994-02-04 1995-08-10 William Ward Indicateur bioluminescent fonde sur l'expression d'un gene codant pour une proteine modifiee a fluorescence verte
US5795737A (en) * 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
US5777079A (en) * 1994-11-10 1998-07-07 The Regents Of The University Of California Modified green fluorescent proteins
US5958713A (en) * 1995-01-31 1999-09-28 Novo Nordisk A/S Method of detecting biologically active substances by using green fluorescent protein
CA2217700C (fr) * 1995-01-31 2002-12-17 Novo Nordisk A/S Procede de detection de substances biologiquement actives
WO1996027027A1 (fr) * 1995-03-02 1996-09-06 Rutgers The State University Of New Jersey Procede ameliore visant a purifier une proteine a fluorescence verte
GB9504446D0 (en) * 1995-03-06 1995-04-26 Medical Res Council Improvements in or relating to gene expression
US5741657A (en) 1995-03-20 1998-04-21 The Regents Of The University Of California Fluorogenic substrates for β-lactamase and methods of use
US6342379B1 (en) 1995-06-07 2002-01-29 The Regents Of The University Of California Detection of transmembrane potentials by optical methods
DK0851874T3 (da) * 1995-09-22 2000-03-06 Bioimage A S Hidtil ukendte varianter af grønt fluorescerende protein, GFP
US5874304A (en) * 1996-01-18 1999-02-23 University Of Florida Research Foundation, Inc. Humanized green fluorescent protein genes and methods
US6803188B1 (en) * 1996-01-31 2004-10-12 The Regents Of The University Of California Tandem fluorescent protein constructs
US5804387A (en) * 1996-02-01 1998-09-08 The Board Of Trustees Of The Leland Stanford Junior University FACS-optimized mutants of the green fluorescent protein (GFP)
US6027881A (en) * 1996-05-08 2000-02-22 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Mutant Aequorea victoria fluorescent proteins having increased cellular fluorescence
US5925558A (en) 1996-07-16 1999-07-20 The Regents Of The University Of California Assays for protein kinases using fluorescent protein substrates
US5912137A (en) 1996-07-16 1999-06-15 The Regents Of The University Of California Assays for protein kinases using fluorescent
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US6593135B2 (en) 1996-08-16 2003-07-15 The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon Long wavelength engineered fluorescent proteins
WO1998021355A1 (fr) * 1996-11-15 1998-05-22 Life Technologies, Inc. Mutants de la proteine fluorescente verte
WO1998036081A2 (fr) * 1997-02-13 1998-08-20 Memorial Sloan-Kettering Cancer Center Molecules hybrides pour la detection optique des modifications des micro-environnements cellulaires
US5998204A (en) 1997-03-14 1999-12-07 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6197928B1 (en) 1997-03-14 2001-03-06 The Regents Of The University Of California Fluorescent protein sensors for detection of analytes
US6046925A (en) 1997-04-14 2000-04-04 The Regents Of The University Of California Photochromic fluorescent proteins and optical memory storage devices based on fluorescent proteins
US6008378A (en) 1997-10-21 1999-12-28 The Regents Of The University Of California Synthetic molecules that specifically react with target sequences
US6150176A (en) 1998-06-09 2000-11-21 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
US6140132A (en) 1998-06-09 2000-10-31 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
US6469154B1 (en) 1999-05-21 2002-10-22 The Regents Of The University Of California Fluorescent protein indicators
US7060793B2 (en) 1999-05-21 2006-06-13 The Regents Of The University Of California Circularly permuted fluorescent protein indicators
US7212640B2 (en) 1999-11-29 2007-05-01 Bizjak Karl M Variable attack and release system and method
AU2002254173A1 (en) 2001-03-12 2002-10-08 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The Unive Oxidation-reduction sensitive green fluorescent protein variants

Also Published As

Publication number Publication date
AU4327797A (en) 1998-03-06
EP1508574A2 (fr) 2005-02-23
ATE280178T1 (de) 2004-11-15
US6077707A (en) 2000-06-20
US7560287B2 (en) 2009-07-14
US20030036178A1 (en) 2003-02-20
CA2232242C (fr) 2008-10-21
US20050079525A1 (en) 2005-04-14
CA2232242A1 (fr) 1998-02-19
US6124128A (en) 2000-09-26
ES2231890T3 (es) 2005-05-16
EP0886644B1 (fr) 2004-10-20
EP0886644A1 (fr) 1998-12-30
US6054321A (en) 2000-04-25
US6403374B1 (en) 2002-06-11
DE69731285D1 (de) 2004-11-25
WO1998006737A1 (fr) 1998-02-19
JP2001506842A (ja) 2001-05-29
US6780975B2 (en) 2004-08-24
JP4232992B2 (ja) 2009-03-04
AU727088B2 (en) 2000-11-30
EP0886644A4 (fr) 2000-01-19
DE69731285T2 (de) 2006-03-09
EP1508574A3 (fr) 2005-11-30

Similar Documents

Publication Publication Date Title
DK0886644T3 (da) Lang bölgelængde-modificerede fluorescerende proteiner
DK0939767T3 (da) Procin faktor VIII og hybrider deraf
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
DK0713529T3 (da) Vækst-/differentieringsfaktor af TGF-beta-familien
EP1712623A3 (fr) Sélection de protéines par fusions de proteénes et d'ARN
ATE317908T1 (de) Verfahren zur herstellung von rekombinanten viren
DK0871631T3 (da) Antiparasitære marcfortiner og paraherquamider
DE69938416D1 (de) Kodierung von mehrwortinformation mit wortweiser verschachtelung
DE69534778D1 (en) Cathepsin-02-protease
DE19882430T1 (de) Korrektur von Emissions-Kontamination und Totzeitverlust
DE69832490D1 (de) Vervielfältigung von nukleinsäuren
NO995002L (no) Modifiserte TNF-<alfa>-molekyler, DNA som koder for slike modifiserte TNF-<alfa>-molekyler og vaksiner omfattende slike TNF- <alfa>-molekyler og DNA
ITRM950043A0 (it) Apparecchio e procedimento per le applicazioni di etichette.
DE69921311D1 (de) Vervielfältigung von nukleinsäuren
ATE309356T1 (de) Konstruierte fluoreszenzproteine mit langen wellenlängen
HK1049185A1 (zh) 可改螢光蛋白
DE69728897D1 (de) Saeugetierchemokine
DE59812587D1 (de) System zur optischen Übertragung von Informationen
AU1137699A (en) Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
EA200100110A1 (ru) Нейротрофические факторы
DE59700170D1 (de) Verbesserte Halbbrückenansteuerung von Leuchtstofflampen
DE69832622D1 (de) Methoden zur durchforstung (screenen) von proteinen
WO2001098459A3 (fr) Acides nucleiques codant hei-c, polypeptides hei-c, anticorps hei-c et leurs methodes d'utilisation
HUP9802616A2 (hu) DUEIMVIO fajtanevű, teltvirágú sötétrózsaszínű muskátli (Pelargonium Zonale Hybridae)